NCT04224428View on ClinicalTrials.gov

Role of Fexofenadine in Diabetic Kidney Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Diabetic Kidney Disease
Interventions
DRUG

Fexofenadine Pill

fexofenadine tablets 60 mg once daily will be taken for six months

DRUG

Placebo oral tablet

lactose oral tablet

Trial Locations (1)

Unknown

Faculty of Pharmacy, Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT04224428 - Role of Fexofenadine in Diabetic Kidney Disease | Biotech Hunter | Biotech Hunter